Literature DB >> 8822908

Filgrastim (r-metHuG-CSF): the first 10 years.

K Welte1, J Gabrilove, M H Bronchud, E Platzer, G Morstyn.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8822908

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  93 in total

1.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro.

Authors:  B Hellmich; E Csernok; A Trabandt; W L Gross; M Ernst
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Population pharmacokinetic-pharmacodynamic modeling of filgrastim (r-metHuG-CSF) in healthy volunteers.

Authors:  B Wang; T M Ludden; E N Cheung; G G Schwab; L K Roskos
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-08       Impact factor: 2.745

3.  Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy.

Authors:  Yoshihiro Yakushijin; Hisaharu Shikata; Ikue Takaoka; Tamami Horikawa; Kazuhito Takeuchi; Jun Yamanouchi; Taichi Azuma; Hiroshi Narumi; Takaaki Hato; Masaki Yasukawa
Journal:  Int J Clin Oncol       Date:  2010-10-06       Impact factor: 3.402

Review 4.  Ethical problems of evaluating a new treatment for melioidosis.

Authors:  Allen C Cheng; Michael Lowe; Dianne P Stephens; Bart J Currie
Journal:  BMJ       Date:  2003-11-29

5.  Recombinant filgrastim (BK0023) pharmacodynamics and pharmacokinetics after single and multiple escalating doses in an equivalence study in healthy men.

Authors:  Andrea F D Di Stefano; Gaia Spinetti; Antonio Rusca; Milko M Radicioni; Luca Loprete; Domenica M G Lamparelli; Jutta Michael Hepp; Davide Crobu; Rodolfo Schrepfer; Giancarlo Tonon
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859

Review 6.  Chemokine-mobilized adult stem cells; defining a better hematopoietic graft.

Authors:  L M Pelus; S Fukuda
Journal:  Leukemia       Date:  2007-11-01       Impact factor: 11.528

Review 7.  Hematopoietic cytokines.

Authors:  Donald Metcalf
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

Review 8.  Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand.

Authors:  Louis M Pelus
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

9.  Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.

Authors:  Christian Schneider; Sonja von Aulock; Siegfried Zedler; Christian Schinkel; Thomas Hartung; Eugen Faist
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

10.  NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway.

Authors:  Julia Skokowa; Dan Lan; Basant Kumar Thakur; Fei Wang; Kshama Gupta; Gunnar Cario; Annette Müller Brechlin; Axel Schambach; Lars Hinrichsen; Gustav Meyer; Matthias Gaestel; Martin Stanulla; Qiang Tong; Karl Welte
Journal:  Nat Med       Date:  2009-02-01       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.